S2Medical AB (publ) (FRA:S21)

Market Cap	309.96K -67.2%
Revenue (ttm)	1.35M +2.3%
Net Income	-909.49K
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,000
Open	0.0002
Previous Close	0.0002
Day's Range	0.0002 - 0.0002
52-Week Range	0.0001 - 0.0041
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 17, 2026

About S2Medical AB

S2Medical AB (publ) develops products for wound healing, infection control, and cosmeceuticals spectrum in Sweden. The company offers odor eliminator under the YNOLENS brand; IvaQ, a negative pressure wound therapy (NPWT) system; Instagraft, a technology designed to make skin transplantation even in non-specialist healthcare setting; ADMERCIN, a solution against antibiotic-resistant bacteria; and Epiprotect, a technology designed to protect and support wound healing by creating an environment for tissue recovery. It also provides Symbiovance, a...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2013
• Employees: 10
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: S21

Financial Performance

Financial numbers in SEK

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error